Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.

Source:http://linkedlifedata.com/resource/pubmed/id/19539144

J. Am. Coll. Cardiol. 2009 Jun 23 53 25 2343-8

Download in:

View as

General Info

PMID
19539144